Kymera
phase dose and expansion trials to evaluate in patients with | Kymera
Company
Deck Type
Sector
Industry
Deck date
December 2022
Slide
18 of 63
Similar slides by Kymera
See diffirences between slides (animation)
Investor Presentation
December 2023
| Kymera
Investor Presentation
November 2023
| Kymera
Investor Presentation
August 2023
phase dose and expansion trial to evaluate in adult patients with and solid tumors | Kymera
Investor Presentation
August 2023
phase dose and expansion trials to evaluate in patients with | Kymera
Related slides by other companies
Nuvectis Pharma
Investor Presentation
July 2023
phase underway fast track designation | Nuvectis Pharma
Nuvectis Pharma
Investor Presentation
December 2023
phase underway fast track designation | Nuvectis Pharma
MindMed
Investor Presentation
December 2024
phase gad part a trials primary key secondary | MindMed
Nuvectis Pharma
Investor Presentation
August 2023
phase underway fast track designation | Nuvectis Pharma
Other recent decks by Kymera
See all presentations (7 decks)
Investor Presentation
December 2023
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights